Transforming growth factor (TGF)-β plays crucial roles in differentiation of dendritic cells (DC). However, molecular mechanisms how TGF-β regulates DC differentiation remain largely unknown. Here, we show that selective repression of one of the TGF-β receptor-regulated SMADs (R-SMADs), SMAD3 directs conventional DC (cDC) differentiation, whereas maintenance of SMAD3 is indispensable for plasmacytoid DC (pDC) differentiation. Expression of SMAD3 was specifically downregulated in CD115 + common DC progenitor (CDP), pre-cDCs and cDCs. SMAD3 deficient mice showed a significant reduction in pre-pDCs and pDCs with increased CDP, pre-cDCs and cDCs. SMAD3 upregulated the pDC-related genes: SPI-B, E2-2 and IKAROS, while it repressed FLT3 and the cDC-related genes: IRF4 and ID2. STAT3 and a SMAD transcriptional co-repressor, c-SKI repressed SMAD3 for cDC differentiation, whereas canonical SMAD-mediated TGF-β signalling maintained SMAD3 for pDC differentiation. Thus, SMAD3 is the pivotal determinant to bifurcate cDC and pDC differentiation in the steady-state condition. (145 words)
INTRODUCTION
A web of cytokine signalling pathways and transcription programs control development of DC subsets from distinct hematopoietic lineages (Lin) (Belz et al, 2012; Dress RJ et al, 2018; Merad et al, 2013; Miller et al, 2012; Murphy et al, 2016) . Several cytokine receptors such as Fms-related tyrosine kinase 3 (FLT3; CD135), c-KIT (CD117) and macrophage colonystimulating factor receptor (M-CSFR; CD115) are the markers to distinguish Lin -DC progenitors in mouse bone marrow (BM). Common myeloid progenitors (CMPs), common lymphoid progenitor (CLP) and lymphoid-primed multipotent progenitor (LMPP) are the early DC progenitors, which differentiate into the intermediate progenitor, macrophage DC progenitor (MDP). Downstream of MDP is the common DC progenitors (CDPs) comprised of CD115 + and CD115 -CDPs, which give rise to conventional/classical DC (cDCs) and plasmacytoid DCs (pDCs), respectively, in the steady state condition (Onai et al, 2007; Onai et al, 2016; Schraml et al, 2015) . CDPs give rise to Lin -CD11c + MHCII -CD135 + CD172αpre-DCs divided into four subsets based on the expression of sialic acid binding Ig-like lectin (Siglec)-H and Ly6C, of which SiglecH + subsets have a pDC potential, while SiglecHsubsets have a cDC potential (Schlitzer et al, 2015) . Pre-cDCs have been defined as CD11c + MHCIIproliferative precursor in BM and lymphoid tissues, which differentiate into CD8 + and CD11b + cDCs but not into pDCs (Diao et al, 2006; Naik et al, 2006) . Transcriptome analyses of DC subsets have revealed the essential roles of transcription factors for cDC and pDC differentiation (Miller et al, 2012; Murphy et al, 2016) . The helixloop-helix (HLH) transcription factor, inhibitor of DNA binding protein 2 (ID2) is required for the development of splenic CD8α + DC subset and Langerhans cells (Hacker et al, 2003) .
Interferon regulatory factors (IRF)-2, IRF-4 and IRF-8 regulate cDC and pDC differentiation (Merad et al, 2013) . Basic HLH transcription factor (E protein) E2-2/Tcf4 is a specific transcriptional regulator of pDC, which directly activates pDC-related genes such as Irf8 and YOON et al -4-Spib (Cisse et al, 2008) . ID2 and E2-2 induce cDC and pDC, respectively with mutual antagonism (Ghosh et al, 2010) . The ETS transcription factor, Spi-B expressed in pDC precursors is required for pDC development (Schotte et al, 2003 , Schotte et al, 2004 . E2-2 and Spi-B mutually enhance their expressions and cooperate to induce the development of human pDC (Nagasawa et al, 2008) . IKAROS, a zinc finger protein is required for pDC differentiation by repressing non-pDC gene expression (Allman et al, 2006) . STAT3 is required for FLT3-dependent DC differentiation (Laouar et al, 2003) . Although TGF-β has been reported to regulate some of these factors for DC development as introduced below, network of TGF-β signalling pathways and these transcription factors still remains largely to be determined.
TGF-β pleiotropically regulates hematopoiesis and immune cell development (Blank et al, 2015; Challen et al, 2010; Sanjabi et al, 2017; Söderberg et al, 2009 ). TGF-β exerts the differential effects on DC development in ontogenetic stage-dependent manners (Seeger et al, 2015) . TGF-β promotes DC development from CD34 + hemopoietic progenitors (Riedl et al, 1997; Strobl et al, 1996) . TGF-β1 is required for immature DC development, whereas it blocks DC maturation (Yamaguchi et al, 1997) . TGF-β1 directs differentiation of CDP into cDCs by inducing cDC instructive factors, IRF4 and RelB, and pDC inhibitory factor, ID2 (Felker et al, 2010) . TGF-β1 induces DC-associated genes such as Flt3, Irf4 and Irf8 in multipotent progenitors at steady state (Sere et al, 2012) . Canonical TGF-β signalling pathway is initiated by ligand-bound activated TGF-β type I receptor (TβRI)-phosphorylated TGF-β receptor-regulated SMADs (R-SMADs): SMAD2 and SMAD3. Despite their high homology, SMAD2 and SMAD3 exert the distinct functions depending on the context (Brown et al, 2007; Heldin et al, 2012; Massague et al, 2005) . Signalling mechanisms underlying pleiotropic functions of TGF-β in differentiation of DC subsets from their specific precursors remain unknown.
YOON et al
-5-Here, we have found that SMAD3 is specifically repressed in CD115 + CDP, pre-cDCs and cDCs, despite its ubiquitous and constant expression in normal cells in the steady state condition. SMAD3 represses the transcription factors crucial for cDC differentiation such as FLT3, IRF4 and ID2. We have discovered that STAT3 represses SMAD3 for cDC differentiation in cooperation with c-SKI, one of the SKI/SNO protooncoproteins that inhibit TGF-β signalling as the transcriptional corepressor of the SMAD proteins (Deheuninck et al, 2009; Massague et al, 2005) . By contrast, SMAD3 self-induced by SMAD2/3/4 upregulates the pDC-related genes such as Spi-B, E2-2 and IKAROS for pDC differentiation from pre-pDCs, which are substantially deficient in Smad3 null mice. These findings indicate that downregulation or maintenance of SMAD3 expression determines the fate of DC precursors into cDCs and pDCs.
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RESULTS
Selective downregulation of SMAD3 in cDCs
We examined the basal expression patterns of SMAD2 and SMAD3 in LMPP as Lin -Sca-1 + CD34 + CD117 + CD135 + cells, DC progenitor cells: MDP as Lin -CD117 hi CD135 + CD115 + Sca-1cells, CD115 + CDP as Lin -CD117 int CD135 + CD115 + CD127cells, CD115 -CDP as Lin -CD117 int CD135 + CD115 -CD127cells (Fogg et al, 2006; Onai et al, 2016) , SiglecH -Ly6C -/SiglecH -Ly6C + /SiglecH + CD11c + MHCII -CD135 + CD172αpre-DCs (Schlitzer et al, 2015) and differentiated DCs: BM CD11c hi cDCs, BM PDCA-1 + pDCs, splenic CD11c hi cDCs, splenic PDCA-1 + pDCs, lamina propria and Peyer's patch cDCs of C57BL/6 mice. We also examined GM-CSF plus IL-4-induced BM-derived DCs (BMDCs) that yield CD11b + cDCs and FLT3L-induced BMDCs that yield both cDCs and pDCs (Waskow et al, 2008; Yamaguchi et al, 1997) . SMAD2 mRNA was expressed in all examined cells, whereas SMAD3 mRNA expressed in MDP, CD115 -CDP, SiglecH + pre-pDCs and pDCs was reduced to almost undetectable level in CD115 + CDP, SiglecHpre-cDCs and cDCs ( Figure 1A and S1A). Immunoblotting confirmed that SMAD2 protein (60 kDa) kept expressed, whereas SMAD3 protein (50 kDa) expressed in whole BM was reduced to undetectable level in GM-CSF plus IL-4-induced BMDCs ( Figure S1B ). Immunocytochemistry using proximity ligation assay (PLA) showed that SMAD3 protein expressed in LMPP, MDP, CD115 -CDP, SiglecH + pre-pDCs and pDCs was not detected in CD115 + CDP, SiglecHpre-cDCs and cDCs, whereas SMAD2 protein was expressed in all subsets ( Figure 1B and S1C). SMADs are usually ubiquitously expressed in normal cells (Brown et al, 2007) as we observed their expression in naïve and activated CD4 + T cells and macrophages ( Figure S1D ). Thus, SMAD3 is selectively and specifically downregulated in cDCs from their upstream developmental stage at CD115 + CDP.
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SMAD3-mediated TGF-β signalling induces pDC while inhibits cDC differentiation
Mutually exclusive expression patterns of SMAD3 in cDCs and pDCs led us to examine the effects of forced expression or knockdown of SMAD3 on DC differentiation using FLT3Linduced or GM-CSF plus IL-4-induced BMDCs transfected with either SMAD3 DNA or SMAD3 siRNA four hours prior to culture. Overexpression of SMAD3 resulted in significant increase in MDP and CD115 -CDP while substantial loss of CD115 + CDP in FLT3L-induced BMDCs (Figure 2A , upper panels). By contrast, knockdown of SMAD3 significantly decreased MDP, while increased CD115 + CDP in both FLT3L-induced or GM-CSF plus IL-4-induced BMDCs (Figure 2A and S2A, lower panels). Forced expression of SMAD3 resulted in significant decrease in MHCII + CD11c + , CD11b + CD11c + cDCs and CD24 + CD11c + cDCs with significant increase in PDCA-1 + B220 + pDCs in FLT3L-induced BMDCs, whereas knockdown of SMAD3 resulted in significant increase in MHCII + CD11c + , CD11b + CD11c + cDCs and CD24 + CD11c + cDCs with significant decrease in PDCA-1 + B220 + pDCs in both FLT3L-induced and GM-CSF plus IL-4-induced BMDCs ( Figure 2B and S2B). Forced expression of SMAD3 slightly induced pDCs even in GM-CSF plus IL-4-induced BMDCs, which do not develop pDC ( Figure S2A and S2B). Forced expression of SMAD3 showed the plasmacytoid morphology with no dendrite formation, whereas knockdown of SMAD3 developed more dendrites compared with control pcDNA or siRNA in BMDCs ( Figure 2C and S2C). Knockdown or forced expression of SMAD3 was confirmed by RT-PCR ( Figure   S2D ). SMAD2 and SMAD3 are the R-SMADs shared by TGF-β and Activin among TGF-β superfamily cytokines (Massague et al, 2005) . Activin A (10 ng/ml) showed no effect on FLT3L or GM-CSF plus IL-4-induced BMDC differentiation ( Figure 2D 
Decreased pDCs and increased cDCs in Smad3 -/mice
We next examined the in vivo effect of SMAD3 deficiency on DC differentiation using Smad3 -/mice. We confirmed that the proportions of the hematopoietic progenitor cells detected as c-kit + Lin -Sca-1 + (KLS) or CD34 + KLS cells, LMPP, CMP as Lin -Sca-1 -CD16/32 -CD34 + CD117 + and granulocyte macrophage progenitor (GMP) as Lin -Sca-1 -CD16/32 + CD34 + CD117 + were unaltered in BM of 8-weeks old Smad3 -/mice compared with BM of Smad3 +/+ mice bred in specific-pathogen free environment before the onset of any signs of inflammation (Yang et al, 1999; Yoon et al, 2015) ( Figure S3 ). We observed the significantly increased CD115 + CDP with decreased MDP and unaltered CD115 -CDP in BM of Smad3 -/mice compared with BM of Smad3 +/+ mice ( Figure 3A ). DNGR-1 (encoded by the Clec9a gene and also known as CLEC9A and CD370) positive CDPs are cDC-restricted (Schraml et al, 2013) . CX3CR1 is expressed on MDP and cDC-P (Liu et al, 2009 ). Cx3cr1
and Dngr1 mRNA expression in Lin -CD115 + BM cells and CX3CR1 + CD370 + Lin -CD117 int CD135 + CD115 + BM cells were significantly increased in Smad3 -/mice compared with Smad3 +/+ mice ( Figure 3B ). SiglecH + pre-DCs containing a pDC potential were profoundly reduced, while SiglecH -Ly6C + and SiglecH -Ly6Cpre-DCs with a cDC potential were significantly increased in BM of Smad3 -/mice compared with BM of Smad3 +/+ mice ( Figure 3C ). Total cDCs in BM, spleen, superficial and mesenteric lymph nodes of Smad3 -/mice were significantly increased compared with those of Smad3 +/+ mice, whereas SiglecH + PDCA1 + B220 + pDCs were substantially undetected in those of Smad3 -/mice ( Figure 3D ). Immunophenotyping of DC subsets in Smad3 deficient mice shows that YOON et al -9-SMAD3 deficiency facilitates cDC differentiation at the developmental stage between MDP and CD115 + CDP, while it blocks differentiation of pre-pDCs and pDCs in the steady state.
SMAD3 represses cDC-related genes while induces pDC-related genes
To identify the responsible genes to facilitate cDC while to inhibit pDC differentiation in Smad3 -/mice, we compared the mRNA expressions of the cytokines, their signalling molecules and the transcription factors essential for DC differentiation in DC precursors and subsets of Smad3 -/mice with those of littermate control Smad3 +/+ mice. It was impossible to sort out pre-pDCs and pDCs from BM and lymphoid organs of Smad3 -/mice because they were substantially deficient ( Figure 3C and 3D). Smad3 -/-CD115 + CDPs, pre-cDCs and cDCs expressed significantly higher levels of cDC-related genes: Flt3, Irf4 and Id2 compared with Smad3 +/+ controls, whereas Smad3 -/and Smad3 +/+ CD115 -CDPs expressed similar levels of pDC markers: Siglech (Takagi et al, 2011) , Bst2 encoding PDCA-1 (Blasius et al, 2006) and the transcription factors essential for pDC differentiation: Spib, E2-2 and Ikaros ( Figure 4A ).
To identify the target genes for SMAD3 to induce pDC while to inhibit cDC differentiation, we screened these genes in BMDCs transfected with either SMAD3 DNA or control pcDNA.
We found that forced expression of SMAD3 significantly upregulated the mRNA expression of pDC-related genes: Spib, E2-2 and Ikaros in FLT3L-induced BMDCs ( Figure 4B and S4A). SMAD3 slightly upregulated these pDC-related genes even in GM-CSF plus IL-4induced BMDCs ( Figure S4A and S4B). Low concentrations of TGF-β1 (0.1, 0.2 ng/ml) showed the same effect with forced expression of SMAD3 on these pDC-related genes in both FLT3L-induced and GM-CSF plus IL-4-induced Smad3 +/+ BMDCs, which was abolished in Smad3 -/-BMDCs ( Figure 4C 
TGF-β induces transactivation of the Smad3 gene, thereby pDC differentiation
Because low concentration of TGF-β upregulated pDC-related genes while repressed cDCrelated genes, we examined the dose effect of TGF-β on DC differentiation. In accordance with the effect on the gene expression, low concentrations of TGF-β1 significantly increased pDC differentiation while suppressed cDC differentiation in FLT3L-induced BMDCs, which was abolished in Smad3 -/-BMDCs ( Figure 5A ). Low concentrations of TGF-β1 induced pDC differentiation even in GM-CSF plus IL-4-induced Smad3 +/+ BMDCs, which was abolished in Smad3 -/-BMDCs ( Figure 5B ). High concentrations of TGF-β1 potently inhibited both pDC and cDC differentiation ( Figure 5A and 5B). SMAD3 was C-terminally phosphorylated in the nuclei in CD115 -CDP, pre-pDCs and pDCs ( Figure 1B and S1C). PLA showed that low concentrations of TGF-β1 upregulated the expression and C-terminal phosphorylation levels of SMAD3 proteins ( Figure 5C ). These data verify that SMAD3-mediated low-dose TGF-β signalling induces pDC while represses cDC differentiation.
To investigate the mechanisms how TGF-β signalling maintains the Smad3 mRNA expression for pDC differentiation, we examined the effect of SMAD-mediated TGF-β signalling on the Smad3 gene promoter activity using the luciferase reporter spanning 2 kilobase upstream of the first exons of the Smad3 genes transfected in FLT3L-induced BMDCs. TGF-β1 induced the Smad3 promoter activity in a dose-dependent manner ( Figure   5D ). Discrepancy between lower SMAD3 protein expression and the dose dependency YOON et al -11-observed in luciferase assay in FLT3L-induced BMDCs treated with the high concentrations of TGF-β1 (0.5, 1.0, 5.0 ng/ml) might be due to the potent inhibition of total DC differentiation ( Figure 2D and S2E) and the ligand-dependent degradation of SMAD3 (Fukuchi et al, 2001) . SMAD2, SMAD3, SMAD4 and their transcription coactivator and histone acetyl-transferase p300 (Massague et al, 2005; Heldin et al, 2012) synergistically induced the Smad3 promoter activity as well as TGF-β1 ( Figure 5E ). Chromatin immunoprecipitation (ChIP) showed that SMAD2, SMAD3, SMAD4 and p300 were bound to the same sites in PDCA1 + cells isolated from FLT3L-induced BMDCs (-1700 to -1534 and -524 to -372), which were epigenetically active with acetyl histone H3K23 and trimethyl histone H3K27 ( Figure 5F ). Taken together, transactivation of SMAD3 via canonical TGF-β signalling pathway initiated by low-dose TGF-β induces the essential transcription factors for pDC differentiation.
STAT3 and c-SKI repress transcription of SMAD3 for cDC differentiation
We next investigated the mechanisms how SMAD3 is downregulated in CD115 + CDP for cDC differentiation. The ligand of CD115, M-CSF induces STAT3 activation in macrophages (Novak et al, 1995) . STAT3 functions as the signalling molecule of FLT3L and GM-CSF Onai et al, 2006; Wan et al, 2013) and is essential for FLT3Lresponsive DC progenitor proliferation (Laouar et al, 2003) . Thus, we examined the effect of STAT3 on SMAD3 expression in BMDCs transfected with STAT3 and control pcDNA or siSTAT3 and control siRNA. Forced expression of STAT3 suppressed, whereas knockdown of STAT3 upregulated the expression of Smad3 mRNA ( Figure 6A and S5A ). We examined whether and how STAT3 regulates the Smad3 gene promoter activity using the Smad3 gene promoter luciferase reporter construct transfected in FLT3L-induced or GM-CSF plus IL-4induced BMDCs. CD11b + cells were sorted as cDCs before cell lysis for FLT3L-induced YOON et al -12-BMDCs. SMAD2 and SMAD3 synergistically induced the Smad3 promoter activity, which was repressed by STAT3 ( Figure 6B and S5B) . We screened the representative transcriptional repressors of R-SMADs: SKI/SnoN and TGIF as a corepressor of STAT3 (Deheuninck et al, 2009; Heldin et al, 2012; Massague et al, 2005) . Among them, c-SKI showed the synergy with STAT3 to repress the Smad3 promoter activity ( Figure S5C ).
Knockdown or forced expression of c-SKI and STAT3 showed the same effect on Smad3 mRNA expression in FLT3L-induced and GM-CSF plus IL-4-induced BMDCs (Figure 6A and S5A). Knockdown of c-SKI by siRNA completely abolished the repressive effect of STAT3 on the SMAD2/3-induced Smad3 promoter activation ( Figure 6C and S5D) . By contrast, c-SKI alone retained the repressive effect on the SMAD2/3-induced Smad3 promoter activation when STAT3 was knocked-down, although the synergistic repressive effect of c-SKI and STAT3 was more effective ( Figure 6D ). ChIP showed that SMAD2 was bound to the same sites with STAT3 and c-SKI in FLT3L-induced BMDCs (-1196 to -1003 and -220 to -28), which were epigenetically inactive with trimethyl histone H3K27 ( Figure   6E ). These data indicate that STAT3 in synergy with c-SKI represses SMAD-induced transcription of the Smad3 gene for cDC differentiation.
Interaction of phosphorylated STAT3 with c-SKI is essential for repression of SMAD3 in cDC
We sought to confirm the physiological interactions between STAT3, c-SKI and SMAD2 in DC progenitors, pre-DCs, DC subsets, FLT3L-induced and GM-CSF plus IL-4-induced BMDCs. PLA showed the interaction of c-SKI with STAT3 and SMAD2 in CD115 + CDP, pre-cDCs, cDCs and CD11c hi BMDCs, but not in the early progenitors, pre-pDCs and pDCs ( Figure 7A and S6A) . Knockdown of c-SKI by siRNA abolished the interaction of SMAD2 YOON et al -13-and STAT3, whereas knockdown of STAT3 had no effect on the interaction of c-SKI and SMAD2 in CD11c hi BMDCs ( Figure 7B ).
We next investigated the mechanisms how c-SKI and STAT3 repress transcription of the
Smad3 gene using the Smad3 gene promoter luciferase reporter construct with various combinations of mutants of c-SKI and STAT3 transfected in CD11b + FLT3L-induced or GM-CSF plus IL-4-induced BMDCs. SKI interacts with SMAD2 and SMAD3 through its Nterminal region or with SMAD4 through its SAND-like domain to block the ability of the SMAD complexes to activate transcription of TGF-β target genes (Akiyoshi et al, 1999; Massague et al, 2005; Suzuki et al, 2004; Takeda et al, 2004) . A mutant of c-SKI that does not interact with SMAD2/3 (Δ2/3) failed to repress the Smad3 promoter activity, whereas a mutant of c-SKI that does not interact with SMAD4 (W274E) (Wu et al, 2002) retained the repressive effect on the Smad3 promoter activity ( Figure 7C and S6B) . Transfection of Δ2/3 and c-SKI siRNA failed to induce cDC differentiation, whereas W274E significantly upregulated cDC differentiation as well as wild type c-SKI ( Figure 7D and S6C) . These data verify that interaction of c-SKI with SMAD2 and SMAD3 is required for STAT3-mediated repression of SMAD3 and cDC differentiation. STAT3 is phosphorylated at Y705 and S727 residues upon stimulation (Hillmer et al, 2016) . Inactive mutants of STAT3 at Y705 and S727 residues, Y705F and S727A, respectively, abolished the repressive effect on SMAD2/3induced Smad3 promoter activition in CD11b + FLT3L-induced or GM-CSF plus IL-4-induced BMDCs (Figure 7E and S6D ). Forced expression of STAT3 signifiantly upregulated cDC differentiation to the same degree as forced expression of c-SKI, which was abolised by Y705F and S727A mutations to the same degree as STAT3 siRNA ( Figure 7F and S6E) .
Thus, c-SKI is necessary for phosphorylated STAT3 at Y705 and S727 to interact with TGFβ R-SMADs to repress transcription of the Smad3 gene for cDC differentiation.
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DISCUSSION
Major DC subsets are classified into cDCs and pDCs, even though recent studies have shown increasingly complex classification of DC subpopulations and progenitors during ontogeny (Dress et al, 2018) . Signalling mechanisms how TGF-β regulates the differentiation of DC subsets in the steady state remained largely unknown, although its importance in immunogenic and tolerogenic functions of the differentiated DCs have been appreciated (Seeger et al, 2015) . In this study, specific repression of SMAD3 in cDCs and their progenitors: pre-cDCs and CD115 + CDP led us to uncover its pivotal role to bifurcate DC differentiation into cDCs and pDCs.
SMAD2 and SMAD3 are ubiquitously and constitutively expressed in normal cells in general, whereas their loss is frequently observed in various cancers (Brown et al., 2007; Heldin et al., 2012) . They have high amino acid sequence identity in their MH2 domains containing two C-terminal serine residues, 465/467; nevertheless they regulate the same or distinct sets of TGF-β target genes to exert redundant or distinct functions depending on the context (Brown et al, 2007 , Massague et al, 2005 . However, the precise mechanisms how they are selected for distinct functions by the context still remain largely unknown. In order to prevent continuous SMAD-mediated TGF-β signalling in normal epithelial cells, SMAD2 and SMAD3 are negatively regulated by diverse mechanisms (Brown et al, 2007) . TGF-β has been shown to downregulate SMAD3 in lung epithelial cells through decreased transcription (Yanagisawa et al, 1998) or in epitheilial-to mesenchymal transition of human glomerular mesangial cells through decreased transcription and increased ubiquitination (Poncelet et al, 2007) , suggesting that downregulation of SMAD3 can be one of the mechanisms to select the appropriate R-SMAD in response to TGF-β by the context. This study is the first to show that the transcriptional downregulation of SMAD3 is indispensable for differentiation of the normal immune cell subsets in the steady-state. Further studies are required to explore the YOON et al -15-distinct regulation of R-SMADs in immune cells including the effector DC subsets in the pathophysiological setting (Merad et al, 2013) .
This study shows that STAT3 transcriptionally represses SMAD3 to derepress cDC-related genes: IRF4, ID2 and FLT3 in cDCs, pre-cDC and CD115 + CDP. Indispensable role of STAT3 in DC development has been shown by loss of cDCs by deletion of STAT3 in vivo (Laouar et al, 2003) and promotion of DC maturation from the progenitors by overexpression of STAT3 (Onai et al, 2006) . Engagement of FLT3L and FLT3 expressed on DC precursors such as MDP, CDPs, and pre-cDCs (Liu et al, 2009; Onai et al, 2007) induces rapid phosphorylation of STAT3 and FLT3L-responsive DC progenitor proliferation . STAT3 transiently activated by GM-CSF promotes differentiation of myeloid lineages including cDCs (Merad et al, 2013; Wan et al, 2013) . Colony stimulating factor, the ligand of CD115 induces STAT3 activation (Novak et al, 1995) . This study has revealed the previously unknown mechanism how STAT3 induces cDC differentiation through repressing SMAD3, a repressor of the representative cDC-related genes.
We have further elucidated that c-SKI is required for STAT3 to repress SMAD3 for cDC differentiation. SKI and the closely related SnoN oncogenes act as transcriptional corepressors in TGF-β signalling through interaction with SMADs (Akiyoshi et al, 1999; Suzuki et al, 2004; Wu et al, 2002) . Although SKI is more widely expressed than SnoN in mature hematopoietic cells and play crucial roles in hematopoiesis and myeloproliferative diseases (Pearson-White et al, 1995; Singbrant et al, 2014) , very little was known about its roles in differentiation and functions of immune cells. We have previously shown that SKI and SnoN oncoproteins cooperate with phosphorylated STAT3 in an adenocarcinoma lung cancer cell line, HCC827 to repress transcription of the Smad3 gene, which renders the sensitive cells resistant to gefitinib (Makino et al, 2017) . Here, we have found that c-SKI, but not SnoN is indispensable for STAT3 to repress the Smad3 gene for cDC differentiation YOON et al -16-rather than playing a conventional role as a transcriptional co-repressor of SMADs. In hematopoietic cells, SKI represses retinoic acid receptor signalling (Dahl et al, 1998) , which enhances SMAD3/SMAD4-driven transactivation (Pendaries et al, 2003) . SKI induces a gene signature associated with hematopoietic stem cells (HSCs) and myeloid differentiation, as well as hepatocyte growth factor (HGF) signalling (Singbrant et al, 2014) . These previous reports and our finding suggest the possibility that HGF signals via STAT3 (Schaper et al, 1997 ) might induce synergy with c-SKI to repress SMAD3 toward myeloid differentiation.
Distinct binding sites of SMADs, p300, STAT3 and c-SKI in the Smad3 promoter in pDCs and cDCs shown in this study and HCC827 lung cancer cell line are consistent with the previous report showing that cell-type-specific master transcription factors direct SMAD3 to distinct specific binding sites to determine cell-type-specific responses to TGF-β signaling (Mullen et al, 2011) .
Studies prior to the identification of distinct CDP subsets (Onai et al, 2013) have shown that TGF-β facilitates cDC differentiation from CDP by inducing the essential factors for cDC differentiation such as IRF4, IRF8, RelB, ID2 and FLT3 (Felker et al, 2010; Sere et al, 2012) .
They have reported that TGF-β induces ID2 (Hacker et al, 2003) . By contrast, TGF-β represses ID2 in epithelial cells (Zavadil et al, 2005) , which is consistent with our data. The discrepancy between these previous reports and this study may be attributed to their two-step amplification and differentiation culture systems. The first-step amplification culture contains SCF, hyper-IL-6 and insulin-like growth factor-1, which modulate STAT and SMAD signalling pathways (Rojas et al, 2016; Sarenac et al, 2016; Yoon et al, 2015) . They report that the amplified DC precursor cells with these cytokines prior to DC differentiation are CDP (Felker et al, 2010) , which may be regulated by TGF-β through a mechanism distinct from the upstream progenitor cells. The second-step differentiation culture contains GM-CSF and IL-4. However, neither TGF-β nor forced expression and knockdown of SMAD3 YOON et al -17-affected the expression of ID2 in GM-CSF plus IL-4-induced BMDCs in our system. Moreover, the expression of ID2 is not downregulated as deduced from these reports, but rather significantly upregulated in cDCs, pre-cDCs and CD115 + CDP in Smad3 -/mice. These data support the pre-selection of committed CDP subset(s) in the first-step culture containing FLT3L in these previous reports.
In contrast with the repressive effect on cDC-related genes, SMAD3 induces pDC-related genes. Consistently, we have found that SMAD3 deficiency in vivo resulted in substantial loss of pDCs and pre-pDCs, indicating the indispensable role of SMAD3 for pDC differentiation at the developmental stage of pre-pDCs. We have found that low-dose TGF-β in vitro that represents in vivo steady-state physiological function (Zi et al, 2012) transactivates SMAD3 in BMDCs, which then induces pDC-related genes: Spib, Tcf4 and Ikaros (Allman et al, 2006; Cisse et al, 2008; Ghosh et al, 2010; Nagasawa et al, 2008 , Reizis et al, 2019 . Significantly more profound decrease of pDCs in SMAD3 deficient mice compared with the mice deficient in E2-2 (Ghosh et al, 2010; Grajkowska et al, 2017) also supports our finding that SMAD3 is the upstream inducer of these pDC-related genes. The proximal promoter regions of these pDC-related genes and pDC marker genes: Siglech, Bst2 upregulated by SMAD3-mediated TGF-β signalling are relatively abundant in the SMAD3/SMAD4 binding sequence termed CAGA box (Dennler et al, 1998) . In the light of ubiquitous expression of SMAD3 in the steady-state condition, future studies are required to identify the factors networking with SMAD3 to specifically induce pDC differentiation.
TGF-β exerts the bidirectional effects on proliferation and differentiation vs. quiescence depending on the HSC subtypes (Blank et al, 2015) . Extracellular matrix stores and activates latent TGF-β in BM to activate SMAD-mediated TGF-β signalling in HSCs and various hematopoietic progenitor cell populations (Massague, et al, 2012; Robertson, et al, 2016; Soderberg et al, 2009 ). TGF-β induces HSC hibernation (Yamazaki et al, 2009 ). TGF-β-YOON et al -18-SMAD3 signalling has been implicated to connect FOXO-p57Kip2 signalling to induce HSC quiescence and self-renewal (Naka et al, 2017) . Considering the crucial role of SMAD3 in maintaining stem cell quiescence reported in these previous studies, nuclear localization of R-SMADs in freshly isolated BM progenitor cells suggests that the early DC progenitors upstream of MDPs are maintained by SMAD-mediated canonical TGF-β pathway.
In summary, we demonstrate the previously unknown fate determinant roles of SMAD3 as a negative regulator of cDC differentiation and a positive regulator of pDC differentiation in the steady-state. Repression of SMAD3 by phosphorylated STAT3 and c-SKI is required for commitment to cDC, whereas maintenance of SMAD3 via canonical TGF-β signalling is required for pDC differentiation. Although we have narrowed down CD115 + CDP and pre-pDC in which SMAD3 expression is regulated for differentiation of cDC and pDC, respectively, our findings would have potential for future studies to identify the unknown lineage-specific DC progenitor cells targeted by SMAD3. 
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